Last update :
23/11/2022
Analgesic   Remifentanil hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fenburol Chile, Republic of South Africa
Proximicil Mexico
Redormin Argentina
Remicit Argentina
Remifas Ecuador
Remifentanil Belgium, Canada, Germany, Iceland, New Zealand, Norway, Romania
Remifentanilo Argentina, Portugal, Spain
Remiflo Argentina
Remimed Germany
Restinil Argentina, Ecuador
Sagal Argentina
Ultiva Australia, Austria, Belgium, Chile, Colombia, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iran, Ireland, Italy, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, United States of America, Venezuela
Stability in solutions   Injection   Stability in solutions : Remifentanil hydrochloride     
Container Solvent Concentration Temperature Storage Duration References
Glass Water for Injection 10 >> 50 µg/ml 20-22°C Not specified
24 Hour
4501

Glass Sodium chloride 0,9% 10 >> 50 µg/ml 20-22°C Not specified
24 Hour
4501

Not specified Water for Injection 20 >> 250 µg/ml 25°C Not specified
24 Hour
3519
Manufacturer's stability data

Not specified NaCl 0,9% or Glucose 5% 20 >> 250 µg/ml 25°C Not specified
24 Hour
3519
Manufacturer's stability data

Not specified Sodium chloride 0,45% 20 >> 250 µg/ml 25°C Not specified
24 Hour
3519
Manufacturer's stability data

Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 2-8°C Not specified
21 Day
4192
Level of evidence C

Polypropylen Syringe Sodium chloride 0,9% 10 µg/ml 23-27°C Not specified
90 Day
4183
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 20 µg/ml 2-8°C Not specified
21 Day
4192
Level of evidence C

Polypropylen Syringe Sodium chloride 0,9% 4 µg/ml 23-27°C Not specified
90 Day
4183
Level of evidence A

Polypropylen Syringe Sodium chloride 0,9% 4 & 10 µg/ml 23°C Not specified
90 Day
4231
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 50 µg/ml 2-8°C Not specified
21 Day
4192
Level of evidence C


  Mentions Légales